Enfortumab vedotin induced interstitial lung disease: A first case report with pathological evidence from transbronchial lung cryobiopsy

Enfortumab vedotin induced interstitial lung disease: A first case report with pathological evidence from transbronchial lung cryobiopsy

Enfortumab vedotin (EV), an antibody–drug conjugate targeting Nectin-4, has demonstrated efficacy against advanced urothelial carcinoma. While initially considered rare, EV-induced interstitial lung disease (ILD) is increasingly recognized, yet its pathological features remain poorly characterized....

Full description

Saved in:
Bibliographic Details
Main Authors: Shota Kaburaki, Toru Tanaka, Koichiro Kamio, Yosuke Tanaka, Kazuo Kasahara, Yasuhiro Terasaki, Masahiro Seike
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:Respiratory Medicine Case Reports
Subjects:
Enfortumab vedotin
Interstitial lung disease
Antibody–drug conjugate
Nectin-4
Transbronchial cryobiopsy
Non-specific interstitial pneumonia
Online Access:http://www.sciencedirect.com/science/article/pii/S2213007125000735
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2213007125000735

Similar Items